Renal transplantation at the University of Michigan 1964 to 1999.

J. C. Magee, R. S. Sung, J. G. Turcotte, J. D. Punch, A. O. Ojo, D. M. Cibrik, J. W. Konnak, D. A. Bloom, J. S. Wolf, B. Kaplan, S. M. Rudich, T. E. Bunchman, A. B. Leichtman, R. M. Merion, D. A. Campbell

    Research output: Contribution to journalArticlepeer-review

    5 Scopus citations


    The Michigan Kidney Transplant Program has existed for 35 years. Outcomes have improved dramatically as the one-year survival of cadaver kidney grafts increased from 25% to 85-90%. Patient deaths in the first year are now uncommon. Indications for renal transplantation have been extended to infants, the elderly, diabetics and to patients with other significant health problems who would not have been candidates in the past. Chronic administration of large doses of corticosteroids is no longer necessary and the associated morbidity is largely avoided. Improvements in immunosuppression, especially the introduction of cyclosporine, account for much of this progress. With success has come increasing demand. Unfortunately, the gap between the number of available donor kidneys and the number of patients listed for a cadaver transplant continues to increase rather than diminish. Greater acceptance of volunteer donation, as has occurred in our own program, will help to reduce this shortage. If the past forecasts the future, we can anticipate extraordinary advances during the next 35 years.

    Original languageEnglish (US)
    Pages (from-to)139-148
    Number of pages10
    JournalClinical transplants
    StatePublished - 1999

    ASJC Scopus subject areas

    • Medicine(all)


    Dive into the research topics of 'Renal transplantation at the University of Michigan 1964 to 1999.'. Together they form a unique fingerprint.

    Cite this